Skip to content
Review Open access

HIV-1 Env Heterogeneity: Cleavage, Trafficking, and Antigenic Consequences for Virions and Infected Cells

Jul 2026 · Viruses · Vol 18, pp. 811 · 0 citations · 132 references
Medicine

TL;DR

A focused review of how Env endocytosis and recycling influence Env incorporation into virions and antibody recognition, and how Env cleavage may influence trafficking and endocytic fate is considered.

Abstract

The HIV-1 Env glycoprotein mediates both cell-free and cell-to-cell viral transmission and represents the primary target for protective humoral immune responses. Studies examining antibody neutralization of cell-free and cell-to-cell HIV transmission have found that cell-to-cell transmission is more resistant to neutralization. This resistance may be explained in part by antigenically distinct Env populations on virions and infected cells. Cell-surface Env may be more heterogeneous due to variations in cleavage, glycosylation, and conformational state. Nevertheless, the mechanisms that maintain antigenically distinct Env populations at the cell surface and on virions remain unclear, despite virion assembly occurring at the plasma membrane. In this focused review, we consider how Env endocytosis and recycling influence Env incorporation into virions and antibody recognition. We further consider how Env cleavage may influence trafficking and endocytic fate. Given the central role of Env’s cytoplasmic tail in engaging endosomal trafficking pathways, we review emerging structural models of the CT and discuss how its organization, symmetry, and conformational flexibility may contribute to Env trafficking and intracellular sorting. We also discuss how heterogeneous Env populations may influence antibody susceptibility. Finally, we review therapeutic strategies, including combinatorial antibodies and small-molecule Env modulators, that may enhance antibody recognition of infected cells and virions.

Read PDF

Similar papers

Biophysical Investigation into the Mechanisms Regulating HIV-1 Envelope Glycoprotein Incorporation

Human Immunodeficiency Virus type-1 (HIV-1) infects CD4+ T cells and remains a global pandemic due to our incomplete understanding of the molecular mechanisms underlying its highly coordinated and regulated assembly process and the strategies it uses for immune evasion. For HIV-1 to produce infectious particles, the vi...

Austin R. Clark · 0 citations
Review Open access Sep 2026

Molecular mechanisms of HIV-1 entry into host cells and emerging therapeutic strategies

This review synthesizes current biochemical and structural insights into HIV-1 entry, with emphasis on envelope conformational dynamics, receptor and co-receptor interactions, membrane fusion mechanisms, and host determinants that regulate entry efficiency and tropism.

Lamarana Jallow, P. Quashie · 0 citations
Open access Sep 2026

Vpu protects HIV-infected cells from antibody-dependent cellular phagocytosis by counteracting tetherin.

Tetherin is an interferon-inducible transmembrane protein that inhibits the detachment of enveloped viruses from infected cells. HIV-1 Vpu counteracts this restriction by removing tetherin from sites of virus release. Accordingly, Vpu mutations that disrupt tetherin antagonism increase Env accumulation on the surface o...

Brian J. Snow, Nida K. Keles, Ahmed Ali et al. · 0 citations
Open access Oct 2026

Distinct allosteric remodeling of HIV-1 Env dynamics on virions by gp41-directed antibodies reveals two modes of neutralization

HIV-1 envelope glycoprotein (Env), a gp120–gp41 trimer, undergoes coordinated conformational changes that drive membrane fusion and allow immune evasion by transiently concealing neutralization-sensitive epitopes. Most broadly neutralizing antibodies (bNAbs) target gp120, whereas a distinct subset recognizes conserved...

Wang Xu, Narendra Kumar Gonepudi, Jun-Yu Liu et al. · 0 citations
Open access Jan 2026

Distinct allosteric remodeling of HIV-1 Env dynamics on virions by gp41-directed antibodies reveals two modes of neutralization

HIV-1 envelope glycoprotein (Env), a gp120–gp41 trimer, undergoes coordinated conformational changes that drive membrane fusion and allow immune evasion by transiently concealing neutralization-sensitive epitopes. Most broadly neutralizing antibodies (bNAbs) target gp120, whereas a distinct subset recognizes conserved...

Wang Xu, Narendra Kumar Gonepudi, Jun-Yu Liu et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.